Germany Colorectal Cancer Diagnostics & Therapy Market: Segmented by Types of Diagnosis & Treatment - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139853
- Pages: 200
-
Format:
Report Overview
Germanys Colorectal Cancer market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX.X% during the forecast period.
Colorectal cancer is the most common cancer in Germany and the second most common cause of cancer-related deaths in both men and women. Germany is also the largest market shareholder for the colorectal Cancer market in Europe.
Market Drivers
The rise in pipeline colorectal cancer screening tests is one of the major drivers for the colorectal cancer market. In Germany, screening colonoscopy with full insurance reimbursement is available for individuals aged 55 and above, and/or for persons with well-known risk factors for CRC.
Furthermore, the companies are focusing more on the development of new diagnostic tests that will help in the accurate detection of colorectal cancer which will further drive the market in future.
1. Germany Colorectal Cancer Market Overview........................
A. Market Size
2. Market Driving and Restraining Factors.
A. Rise in screening tests
B. Development of new diagnostic tests
3. Major Colorectal Cancer Stages
A. Stage 1
B. Stage 2
C. Stage 3
D. Stage 4
4. Colorectal Cancer Market Segmentation........................
A. By Diagnosis
a. X-ray examination
b. Colonoscopy
c. Digital Rectal Examination
d. Fecal Occult Blood Test
e. Flexible Sigmoidoscopy
f. Virtual Colonoscopy
B. By Treatment
a. Surgery
b. Chemotherapy and radiation therapy
c. Hyperthermic intraperitoneal chemotherapy
d. Embolization of hepatic arterial branches
e. Laparoscopic bowel resection
f. Immunotherapy
5. Colorectal Cancer Major Products Market Share
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. B. Braun Melsungen AG Company overview, Product & Services, Strategies & Financials
B. Eli Lilly Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Developments
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
